Browse All Treatments

Showing 1856 records.


Page 39 of 186 1 37 38 39 40 41 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
38119.5 monthsNHL3ChemotherapyShandong Cancer Hospital ChinaJul 2015
Treatment Details: Patients: This study involved 12 elderly primary central nervous system lymphoma patients. The median patient age was 73.9 years (range of 65-84 years) and 9 were male. Treatm... read more
38219.4 monthsMalignant Pleural Mesothelioma4ChemotherapyHyogo College of MedicineJapanJul 2013
Treatment Details: Patients: This study involved 21 malignant pleural mesothelioma patients. The median patient age was 63 years and 76.2% were male. Treatment: Patients received the chemothera... read more
38319.4 monthsRecurrent ovarian cancer4ChemotherapyCharité University Hospital, Campus Virchow-ClinicGermanyAug 2008
Treatment Details: Patients: This phase I/II study involved 26 women with platinum-sensitive recurrent ovarian cancer. Their median age was 62, ranging from 28 to 75 years of age. Treatment: Pa... read more
38419.4 monthsMetastatic breast cancer4Biologic therapyAlbert Einstein College of MedicineUnited StatesApr 2009
Treatment Details: Patients: This phase 2 study involved 33 women with metastatic or surgically incurable advanced breast cancer. They were all post-menopausal. The median age was 61 years, rangin... read more
38519.4 monthsMetastatic, castration-resistant prostate cancer4ChemotherapyThe Cancer Institute of New Jersey, UMDNJ-RWJMSUnited StatesFeb 2010
Treatment Details: Patients: This phase II trial involved 63 men with metastatic castration-resistant prostate cancer that were separated into 2 separate studies (arms). Arm A involved 32 of the me... read more
38619.4 monthsMetastatic, castration-resistant prostate cancer4ChemotherapyCleveland Clinic Taussig Cancer InstituteUnited StatesOct 2010
Treatment Details: Patients: This phase 2 trial involved 35 male metastatic castration-resistant prostate cancer patients with a median age of 67 years and a range of 55-84. Treatment: Patients ... read more
38719.4 monthsHormone-refractory metastatic prostate cancer4ChemotherapyKumamoto UniversityJapanJan 2008
Treatment Details: Patients: This study involved 34 men with hormone-refractory metastatic prostate cancer. The median patient age was 72.3 years. Treatment: Patients were treated with the chem... read more
38819.4 monthsNSCLC5Chemotherapy, Radiation, Biologic therapyUniversity of Texas Health Science CenterUnited StatesSep 2013
Treatment Details: Patients: This phase 2 study involved 40 non-small-cell lung cancer patients with a median age of 67 years; 65% were male. Treatment: Patients were treated with radiation ther... read more
38919.4 monthsStage IIIA NSCLC5Chemotherapy, SurgeryUniversity of Rochester Medical CenterUnited StatesOct 2002
Treatment Details: Patients & Treatment: This Phase III study involved a total of 73 patients with stage IIIA non-small-cell lung cancer. Patients were divided into 5 groups. Group 1 (7 patients) r... read more
39019.3 monthsHormone-refractory prostate cancer5Chemotherapy, Biologic therapyInstitut Jean-GodinotFranceJun 2007
Treatment Details: Patients: This phase II study involved 92 patients with advanced hormone-refractory prostate cancer. The men had received a hormone-based therapy before entering this study, but ... read more
Page 39 of 186 1 37 38 39 40 41 186